Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
12.69
+0.10 (0.79%)
Sep 29, 2026, 11:28 AM EDT - Market open
Cybin Employees
Cybin had 100 employees as of March 31, 2026. The number of employees increased by 50 or 100.00% compared to the previous year.
Employees
100
Change (1Y)
50
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$1,712,040
Market Cap
927.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 100 | 50 | 100.00% |
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Kura Oncology | 260 |
| Alumis | 239 |
| Rigel Pharmaceuticals | 174 |
| Sana Biotechnology | 142 |
| Cullinan Therapeutics | 109 |
| Apnimed | 81 |
| SpyGlass Pharma | 76 |
| Jade Biosciences | 55 |
HELP News
- 5 days ago - Psychedelic: Optimi completes psilocybin production for Phase 2 trial - TheFly
- 6 days ago - Cybin Transcript: TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit - Transcripts
- 6 days ago - Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change - GlobeNewsWire
- 7 days ago - Cybin Transcript: AGM 2026 - Transcripts
- 7 days ago - Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit - GlobeNewsWire
- 8 days ago - Helus Pharma presents new analyses on HLP003 in MDD - TheFly
- 8 days ago - Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026 - GlobeNewsWire
- 8 days ago - Helus Pharma selloff Friday a buying opportunity, says Barclays - TheFly